Digestive Health

News Watch

In this interview, filmed during the 4th Gut Microbiota for Health World Summit, Professor Magnus Simrén of the University of Gothenburg (Sweden) and Chairman of the United European Gastroenterology (UEG) Scientific Committee, explains to Gut Microbiota Worldwatch the relationship between the gut microbiota and irritable bowel syndrome (IBS). The video tells us exactly what irritable bowel syndrome is, what kind of…

GMFH Editing Team
GMFH Editing Team

In this interview, filmed during the 4th Gut Microbiota for Health World Summit, Professor Magnus Simrén of the University of Gothenburg (Sweden) and Chairman of the United European Gastroenterology (UEG) Scientific Committee, explains to Gut Microbiota Worldwatch the relationship between the gut microbiota and irritable bowel syndrome (IBS). The video tells us exactly what irritable bowel syndrome is, what kind of…

GMFH Editing Team
GMFH Editing Team

Abdominal pain, bloating, changes in stool frequency and consistency. These are just some of the symptoms associated with Irritable Bowel Syndrome (IBS), a chronic functional disorder whose origins are unknown. It has no known treatment, only recommendations to keep symptoms at bay. In Western countries, almost two out of ten gastroenterology consultations are motivated by this disorder.   Professor Magnus Simrén, researcher at…

GMFH Editing Team
GMFH Editing Team

Abdominal pain, bloating, changes in stool frequency and consistency. These are just some of the symptoms associated with Irritable Bowel Syndrome (IBS), a chronic functional disorder whose origins are unknown. It has no known treatment, only recommendations to keep symptoms at bay. In Western countries, almost two out of ten gastroenterology consultations are motivated by this disorder.   Professor Magnus Simrén, researcher at…

GMFH Editing Team
GMFH Editing Team

Colorectal cancer (also known as bowel cancer) is the third most common cancer in the world, according to World Cancer Research Fund International. By 2035, it is predicted there will be 2.4 million cases of this type of tumour diagnosed annually worldwide, mostly in developed countries. The risk of developing it is about 1 in 20 (5%) and it is…

GMFH Editing Team
GMFH Editing Team

Colorectal cancer (also known as bowel cancer) is the third most common cancer in the world, according to World Cancer Research Fund International. By 2035, it is predicted there will be 2.4 million cases of this type of tumour diagnosed annually worldwide, mostly in developed countries. The risk of developing it is about 1 in 20 (5%) and it is…

GMFH Editing Team
GMFH Editing Team

As we have explained before in this blog, breast milk is one major way in which an infant’s gut microbiota starts developing. We now know that an antibody contained in breast milk provides lifelong protection from illnesses such as the inflammatory bowel disease (IBD), by setting up defences in the gut flora of breastfed babies. These are the main findings…

GMFH Editing Team
GMFH Editing Team

As we have explained before in this blog, breast milk is one major way in which an infant’s gut microbiota starts developing. We now know that an antibody contained in breast milk provides lifelong protection from illnesses such as the inflammatory bowel disease (IBD), by setting up defences in the gut flora of breastfed babies. These are the main findings…

GMFH Editing Team
GMFH Editing Team

Transferring microbes from the colon of a mouse with a colorectal tumour to a healthy mouse means the latter will also develop cancer, according to a study recently published in mBio® by Zackular JP  et al., the open access journal of The American Academy of Microbiology. It was already known that inflammation played an important role in the development of colorectal…

GMFH Editing Team
GMFH Editing Team

Transferring microbes from the colon of a mouse with a colorectal tumour to a healthy mouse means the latter will also develop cancer, according to a study recently published in mBio® by Zackular JP  et al., the open access journal of The American Academy of Microbiology. It was already known that inflammation played an important role in the development of colorectal…

GMFH Editing Team
GMFH Editing Team

Research & Practice

Gut-related symptoms, including flatulence, bloating, heartburn, nausea, vomiting, constipation, diarrhoea, food intolerance, incontinence, and abdominal pain affect approximately one third of the general population, according to the World Gastroenterology Organisation. Among the functional gastrointestinal disorders (FGIDs) that are characterized by persistent and recurring GI symptoms, irritable bowel syndrome (IBS) affects around 11% of the population globally and can interfere with…

GMFH Editing Team
GMFH Editing Team

Gut-related symptoms, including flatulence, bloating, heartburn, nausea, vomiting, constipation, diarrhoea, food intolerance, incontinence, and abdominal pain affect approximately one third of the general population, according to the World Gastroenterology Organisation. Among the functional gastrointestinal disorders (FGIDs) that are characterized by persistent and recurring GI symptoms, irritable bowel syndrome (IBS) affects around 11% of the population globally and can interfere with…

GMFH Editing Team
GMFH Editing Team

Recent research has pointed to the role of gut microbiota-host interactions in the effectiveness of immunotherapeutic agents (here; here). However, little is known regarding the potential role of the gut microbiota in the immune-mediated effects of drugs used as cancer immunotherapy. A review by Dr. Christian Jobin, from the Department of Medicine, Department of Infectious Diseases and Immunology, and Department…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Recent research has pointed to the role of gut microbiota-host interactions in the effectiveness of immunotherapeutic agents (here; here). However, little is known regarding the potential role of the gut microbiota in the immune-mediated effects of drugs used as cancer immunotherapy. A review by Dr. Christian Jobin, from the Department of Medicine, Department of Infectious Diseases and Immunology, and Department…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

At the end of 2017, GMFH celebrated its 5th anniversary. As a wrap-up of this celebration, we asked members of our Gut Microbiota for Health board of experts to share their thoughts, on video, about these 5 years in which they contributed toward increased knowledge about the gut microbiota and its role in health, and made the initiative what it’s…

GMFH Editing Team
GMFH Editing Team

At the end of 2017, GMFH celebrated its 5th anniversary. As a wrap-up of this celebration, we asked members of our Gut Microbiota for Health board of experts to share their thoughts, on video, about these 5 years in which they contributed toward increased knowledge about the gut microbiota and its role in health, and made the initiative what it’s…

GMFH Editing Team
GMFH Editing Team

Awareness of the importance of the gut microbiota and its role in the health has grown in parallel with research on the subject. Over the past five years, Gut Microbiota for Health has contributed to this awareness not only through its website and digital ecosystem, but also through its annual Gut Microbiota for Health World Summit, specifically addressed to clinical…

GMFH Editing Team
GMFH Editing Team

Awareness of the importance of the gut microbiota and its role in the health has grown in parallel with research on the subject. Over the past five years, Gut Microbiota for Health has contributed to this awareness not only through its website and digital ecosystem, but also through its annual Gut Microbiota for Health World Summit, specifically addressed to clinical…

GMFH Editing Team
GMFH Editing Team

The Gut Microbiota for Health (GMFH) digital community was more active in 2017 than in any previous year—with over 50,000 scientists, healthcare professionals, and members of the public now taking part in the online conversation about gut microbiota! The website had over 950,000 visits this year, and was selected once again as one of Healthline's best gut health blogs. Among…

GMFH Editing Team
GMFH Editing Team

The Gut Microbiota for Health (GMFH) digital community was more active in 2017 than in any previous year—with over 50,000 scientists, healthcare professionals, and members of the public now taking part in the online conversation about gut microbiota! The website had over 950,000 visits this year, and was selected once again as one of Healthline's best gut health blogs. Among…

GMFH Editing Team
GMFH Editing Team